Intec Pharma Ltd.
SEC CIK 1638381 · NTEC · last insider filing 2020-09-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kozarich John W | Director | filed 2019 - 2020 |
| Hayes William B | Director | filed 2019 - 2020 |
| Meckler Jeffrey A | Director · Chief Executive Officer | filed 2019 - 2020 |
| Maddaluna Anthony J | Director | filed 2019 - 2020 |
| Pomerantz Roger | Director | filed 2019 - 2020 |
| Karah Hila | Director | filed 2019 - 2020 |
| Silberman Issac | Director | filed 2019 - 2019 |
| Bianco Gil | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Linscott Walt Addison | Chief Business Officer | filed 2019 - 2020 |
| Sassi Nir | Chief Financial Officer | filed 2019 - 2020 |
| Navon Nadav | Chief Operating Officer | filed 2019 - 2020 |
| Gendreau R Michael | Chief Medical Officer | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.